Funders' Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries

Ana Cardoso-Weinberg; Chris Alley; Linda E Kupfer; Garry Aslanyan; Michael Makanga; Fabio Zicker; Ole F Olesen

doi:10.9745/GHSP-D-21-00497

Funders' Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries

Glob Health Sci Pract. 2022 Apr 29;10(2):e2100497. doi: 10.9745/GHSP-D-21-00497. Print 2022 Apr 28.

Authors

Ana Cardoso-Weinberg¹, Chris Alley², Linda E Kupfer³, Garry Aslanyan⁴, Michael Makanga⁵, Fabio Zicker⁶, Ole F Olesen⁷

Affiliations

¹ European & Developing Countries Clinical Trials Partnership, EDCTP, The Hague, The Netherlands. weinberg@edctp.org.
² Hunter College, City University of New York, New York, NY, USA.
³ Fogarty International Center - National Institutes of Health (NIH), Bethesda, MD, USA.
⁴ TDR, the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland.
⁵ European & Developing Countries Clinical Trials Partnership, EDCTP, The Hague, Netherlands.
⁶ Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
⁷ European Vaccine Initiative (EVI), Heidelberg, Germany & Global Health Section, Department of Public Health, University of Copenhagen, Denmark.

Abstract

We identify and discuss 7 approaches for funders to contemplate when considering support for implementation research in low- and middle-income countries.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Developing Countries*
Global Health
Humans
Income*

Grants and funding

001/WHO_/World Health Organization/International